期刊文献+

胞嘧啶脱氨酶基因联合5-氟胞嘧啶对卵巢癌裸鼠移植瘤的抑制作用 被引量:5

Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo
原文传递
导出
摘要 目的 了解胞嘧啶脱氨酶 (CD)基因联合 5 氟胞嘧啶 (5 FC)对卵巢癌裸鼠皮下移植瘤生长的抑制作用。方法 应用胚肾 2 93细胞扩增整合有CD基因的复制缺陷的腺病毒 ,并将其分离、提纯。以卵巢癌裸鼠模型作为研究对象。实验组 (5只 ) :将整合有CD基因的复制缺陷的腺病毒 0 1ml[1×10 10 菌斑形成单位 (pfu) /ml]注入瘤体内 ,隔日 1次 ,共 3次 ;同时将 5 FC按每次 4 0 0mg/kg注入裸鼠腹腔内 ,每日 2次 ,共 7d。对照组 (5只 ) :以同样方法将同体积生理盐水注入裸鼠体内。观察两组裸鼠的肿瘤生长速度及倍增时间。结果  (1)整合有CD基因的腺病毒滴度为 1 0 7× 10 10 pfu/ml。 (2 )实验组裸鼠肿瘤生长明显受抑制 ,肿瘤体积由 9mm3 增加到 85 5mm3 ,而对照组肿瘤体积由 7mm3 增加到 2 0 14mm3 ,两组比较 ,差异有显著性 (P <0 0 5 ) ,这种显著性差异在用药结束后约 2 0d才表现出来 ,并维持约 30d。(3)实验组与对照组肿瘤倍增时间分别为 (8 1± 0 7)d和 (6 4± 0 7)d ,两组比较 ,差异有显著性 (P<0 0 5 )。结论 应用CD基因联合 5 Objective To evaluate the anticancer effects of cytosine deaminase (CD) gene/5 fluorocytosine (5 FC) to human ovarian papillary serous cystadenocarcinoma in nude mice Methods Replication deficient adenovirus containing CD gene was used to transfect human embryonal kidney cell line 293, and the adenovirus′s concentration was up to 1×10 10 pfu (plaque forming unit)/ml after purification Ten female BULB/C nude mice were implanted subcutaneously with approximate 0 08 g tissue of ovarian papillary serous cystadenocarcinoma from the parental generation, and they were divided into test group and control group While the tumors grew with diameter of approximate 3mm, test group received intratumoral injections of adenovirus CD at 1×10 9 pfu in a 100 μl volume on day 1, 3, 5 These animals were administered 5 FC at doses of 400 mg/kg twice daily by intraperitoneal injection from day 1 to day 7 Normal saline was used in control group with the same volume and by the same methods Tumor volumes were measured in following days Results (1) Compared with control group, the growth of tumors in test group was significantly suppressed Twenty days after the therapies, the tumor volumes in test group and control group were (91±68) mm 3 and (238± 122) mm 3 respectively, there was significant difference This difference lasted for approximately 30 days ( P =0 045-0 019) (2) The mean time of tumor volume doubling in test group and control group were (8 1±0 7)days and (6 4±0 7) days, respectively ( P <0 05) Conclusions This research has shown the significant effects of CD gene/5 FC on human ovarian cancer in nude mice model The results may be the important basis of clinical trials They suggest that this toxic gene/prodrug therapy system may play an important role in ovarian cancer therapy in the future
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2002年第4期195-197,共3页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金资助 (3 9770 770 )
关键词 卵巢肿瘤 核苷酸脱氨酶类 氟胞嘧啶 控制 Ovarian neoplasms Cytosine deaminases Flucytosine
  • 相关文献

参考文献10

  • 1徐丛剑,张惜阴,金志军,姚明,周先荣,丰有吉,许秀兰,顾健人.羟甲基无环鸟苷对携有单纯疱疹病毒胸腺嘧啶核苷激酶基因人卵巢癌裸鼠皮下移植瘤生长的抑制作用[J].中华妇产科杂志,1997,32(12):709-711. 被引量:6
  • 2Pierrefite-Carle V, Baque P, Gavelli A, et al. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst, 1999,91:2014-2019.
  • 3Pederson LC, Buchsbaum DJ, Vickers SM, et al. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res, 1997,57:4325-4332.
  • 4Danielsen S, Kilstrup M, Barilla K, et al. Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase. Mol Microbiol, 1992,6:1335-1344.
  • 5Kievit E, Bershad E, Ng E, et al. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res, 1999,59:1417-1421.
  • 6Blackburn RV, Galoforo SS, Corry PM, et al. Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity. Int J Cancer,1999,82:293-297.
  • 7Wolff G, Korner IJ, Schumacher A, et al. Ex vivo breast cancer cell purging by adenovirus-mediated cytosine deaminase gene transfer and short-term incubation with 5-fluorocytosine completely prevents tumor growth after transplantation. Hum Gene Ther, 1998,9:2277-2284.
  • 8Xie Y, Gilbert JD, Kim JH, et al. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Clin Cancer Res, 1999,5:4224-4232.
  • 9Shirakawa T, Gardner TA, Ko SC, et al. Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model. J Urol, 1999,162:949-954.
  • 10Aghi M, Kramm CM, Chou TC, et al. Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst, 1998,90:370-380.

二级参考文献1

  • 1徐丛剑,中华妇产科杂志,1996年,31卷,664页

共引文献5

同被引文献57

  • 1徐丛剑,许秀兰,张惜阴,郭忠,丰有吉,金志军,曹斌融,顾健人.逆转录病毒介导Ⅰ型单纯疱疹病毒胸腺嘧啶核苷激酶基因转导卵巢癌细胞的研究[J].中华妇产科杂志,1996,31(11):664-666. 被引量:9
  • 2Kanai F, Kawakani T, Hamade, et al. Adenoviras-mediated transduction of E. coil uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil [ J ]. CancerRes, 1998, 58(9) : 1946-1951.
  • 3Uckert W, Kammertons T, Haack K, et al. Double suicide gene(cytosine deaminase and herpes simplex virus thymidine kinase )but not single gene transfer allows reliable elimination of tumor cells in vivo [J]. Hum Gene Ther, 1998, 9(6) : 855-865.
  • 4Furman PA, Mcguirt PV, Keller PM, et al. Inhibition of ACV of cell growth and DNA synthesis of cells biochcmically transformed with herpes virus genetic information[J]. Virol, 1980, 102: 420-430.
  • 5Freeman SM, Abbound CN, Whartenby KA, et al. The "bystander effectn : Tumor regression when a fraction of the tumor mass is genetically modified[J]. Cancer Res, 1993, 53 : 5274-5283.
  • 6Moolten FL. Tumor Chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy[J]. Cancer Res, 1986, 46: 5276-5281.
  • 7Moolten FL, Wells J-M, Heyman RA, et al. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene[J]. Hum C, ene Ther, 1990, 1 : 125-134.
  • 8Moolten FL, Wells JIM. Curability of tumors bearing herpes thymidine kitmse genes transferred by retroviml vectors[J]. J Nail Cancer Inst, 1990, 82(4) : 297-300.
  • 9Behbakht K, Benjamin I, et al. Adenovirus-mediated gene therapy of ovarian cancer in a mouse model [ J ]. Am J Obstet Gynecol,1996, 175(5): 1260-1265.
  • 10Tong XW, Block A, Chen SH, et al. in vivo gene therapy of ovarian cancer by adenoviras-mediated thymidine kinase transduction and gancidovir administration [ J ]. Gynecol Oncol, 1996, 61 :175-179.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部